Vertex’s $10 Billion Acquisition of Crinetics Signals Strategic Move into Specialty Endocrinology Market
In a strategic development within the pharmaceutical sector, Vertex Pharmaceuticals has announced a $10 billion acquisition of Crinetics Pharmaceuticals. This…